Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-25-059791
Filing Date
2025-06-30
Accepted
2025-06-30 17:31:25
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 6876
  Complete submission text file 0001213900-25-059791.txt   8387
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3020 SAPGATE LANE NASHVILLE TN 37207
Business Address
Van Lent Eric R (Reporting) CIK: 0002057653 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38105 | Film No.: 251093430